Paper41442001
Integrated assessment of total airway count and pneumonia volume on chest computed tomography as a prognostic biomarker for coronavirus disease.
Nakagawara K and 32 others. Eur Radiol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Integrated assessment of total airway count and pneumonia volume on chest computed tomography as a prognostic biomarker for coronavirus disease. Papers, record 41442001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41442001
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integrated assessment of total airway count and pneumonia volume on chest computed tomography as a prognostic biomarker for coronavirus disease.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Tomography, X-Ray Computed | Major topic |
| Lung | Major topic |
| Humans | |
| Male | |
| Female | |
| Retrospective Studies | |
| Prognosis | |
| Middle Aged | |
| Aged | |
| SARS-CoV-2 | |
| Japan | |
| Artificial Intelligence | |
| Adult |
Source PubMed
Grants19
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JP20nk0101612 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP20fk0108415 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP21jk0210034 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP21km0405211 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP21km0405217 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP21wm0325031 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP20fk0108452 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP21fk0108563 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP21fk0108553 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP22wm0325031 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP21fk0108431 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP21fk0108510 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP22fk0108513 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP23tm0524008 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP21fk0108573 | the Japan Agency for Medical Research and Development | PubMed | ||
| JP22fk0108537 | the Japan Agency for Medical Research and Development | PubMed | ||
| JPMJCR20H2 | Core Research for Evolutional Science and Technology | PubMed | ||
| JPMJPR21R7 | Precursory Research for Embryonic Science and Technology | PubMed | ||
| 20CA2054 | Ministry of Health, Labour and Welfare | PubMed |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32217835 | Clinical and immunological features of severe and moderate coronavirus disease 2019. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32217835 | PubMed |
| 2 | 34313468 | Post-Acute Sequelae of COVID-19 Pneumonia: Six-month Chest CT Follow-up. | Radiology | 2021 | https://conductscience.org/library/papers/34313468 | PubMed |
| 3 | 36269294 | Physiological impacts of computed tomography airway dysanapsis, fractal dimension, and branch count in asymptomatic never smokers. | J Appl Physiol (1985) | 2023 | https://conductscience.org/library/papers/36269294 | PubMed |
| 4 | 32579236 | Meta-analysis of chest CT features of patients with COVID-19 pneumonia. | J Med Virol | 2021 | https://conductscience.org/library/papers/32579236 | PubMed |
| 5 | 33408642 | Fractal Analysis of Lung Structure in Chronic Obstructive Pulmonary Disease. | Front Physiol | 2020 | https://conductscience.org/library/papers/33408642 | PubMed |
| 6 | 32888496 | Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography. | Cell | 2020 | https://conductscience.org/library/papers/32888496 | PubMed |
| 7 | 28886252 | Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study. | Am J Respir Crit Care Med | 2018 | https://conductscience.org/library/papers/28886252 | PubMed |
| 8 | 32644129 | Persistent Symptoms in Patients After Acute COVID-19. | JAMA | 2020 | https://conductscience.org/library/papers/32644129 | PubMed |
| 9 | 34585270 | External validation of prognostic scores for COVID-19: a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals. | Intensive Care Med | 2021 | https://conductscience.org/library/papers/34585270 | PubMed |
| 10 | 36380316 | Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort study. | Respir Res | 2022 | https://conductscience.org/library/papers/36380316 | PubMed |
| 11 | 35289657 | Quantitative Chest CT Assessment of Small Airways Disease in Post-Acute SARS-CoV-2 Infection. | Radiology | 2022 | https://conductscience.org/library/papers/35289657 | PubMed |
| 12 | 34410886 | Novel Artificial Intelligence-based Technology for Chest Computed Tomography Analysis of Idiopathic Pulmonary Fibrosis. | Ann Am Thorac Soc | 2022 | https://conductscience.org/library/papers/34410886 | PubMed |
| 13 | 36165791 | SARS-CoV-2 Variants Infection in Relationship to Imaging-based Pneumonia and Clinical Outcomes. | Radiology | 2023 | https://conductscience.org/library/papers/36165791 | PubMed |
| 14 | 38663888 | Lung volume measurement using chest CT in COVID-19 patients: a cohort study in Japan. | BMJ Open Respir Res | 2024 | https://conductscience.org/library/papers/38663888 | PubMed |
| 15 | 34621760 | Longitudinal Radiological Findings in Patients With COVID-19 With Different Severities: From Onset to Long-Term Follow-Up After Discharge. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34621760 | PubMed |
| 16 | 37798709 | Clinical utilization of artificial intelligence-based COVID-19 pneumonia quantification using chest computed tomography - a multicenter retrospective cohort study in Japan. | Respir Res | 2023 | https://conductscience.org/library/papers/37798709 | PubMed |
| 17 | 26840053 | Chronic Hypoxia Accentuates Dysanaptic Lung Growth. | Am J Respir Crit Care Med | 2016 | https://conductscience.org/library/papers/26840053 | PubMed |
| 18 | 36510172 | Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force. | BMC Infect Dis | 2022 | https://conductscience.org/library/papers/36510172 | PubMed |
| 19 | 35023191 | Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. | J Med Virol | 2022 | https://conductscience.org/library/papers/35023191 | PubMed |
| 20 | 32345311 | Clinical determinants for fatality of 44,672 patients with COVID-19. | Crit Care | 2020 | https://conductscience.org/library/papers/32345311 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41442001
GET https://conductscience.org/api/papers/v1/41442001/authors?page=2